Deferred revenue makes more sense when you see it walked through with numbers. Below are three examples drawn from subscription commerce — each one shows how cash, deferred revenue, and recognized revenue move on the financial statements.
Example 1: Annual prepay subscription
A coffee subscription costs $15/month or $150/year prepaid. A customer signs up for the annual plan on January 1 and pays $150 immediately.
- Jan 1. Cash +$150, Deferred Revenue +$150 (liability). Revenue $0.
- Jan 31. Deferred Revenue −$12.50, Revenue +$12.50. Deferred Revenue now $137.50.
- Each subsequent month. Another $12.50 moves from deferred to recognized.
- Dec 31. Deferred Revenue $0. Recognized Revenue for the year: $150.
Example 2: Gift subscription
A grandparent buys a 6-month subscription as a gift on November 15. They pay $90. The recipient activates the subscription on December 25.
- Nov 15. Cash +$90, Deferred Revenue +$90. No service delivered yet.
- Dec 25. Subscription activates. First delivery in late December.
- Dec 31. Recognize a partial month of revenue (about $5), reducing deferred revenue accordingly.
- Through June 25. The remaining $85 gets recognized over the next 6 months at $15/month.
Example 3: Bundled annual plan with one-time setup
A skincare brand sells an annual subscription for $240 that includes a one-time onboarding skin assessment (standalone price $40) and 12 monthly product shipments.
- Allocate the contract. Onboarding $40, subscription $200 (12 × ~$16.67).
- When onboarding is delivered. Recognize $40 of revenue. Deferred revenue reduces by $40.
- Each subsequent month. Recognize $16.67 of subscription revenue. Deferred revenue reduces month by month.
- End of year. All $240 recognized; deferred revenue zero.
The pattern across examples
Cash arrives in a lump, revenue gets recognized in pieces matched to delivery, and deferred revenue is the running balance between them. The accounting follows the service, not the money. See deferred revenue for the underlying concept and deferred revenue accounting for the journal entry treatment.